{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-24-000116","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.083326+00:00","generated_at":"2026-05-30T08:06:31.301335+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Penumbra Q3 revenue $301M (+11.1% YoY); U.S. thrombectomy up 21.2%; raises segment guidance","bullets":["Revenue $301.0M, +11.1% YoY; net income $29.5M; adjusted EBITDA $56.7M (18.8% margin).","U.S. thrombectomy revenue $162.1M, +21.2% YoY; VTE franchise grew 32% vs Q3 2023.","GAAP operating income $35.4M vs $12.6M in Q3 2023; non-GAAP operating income $40.3M.","Full-year 2024 revenue reaffirmed $1.18-1.20B; U.S. thrombectomy growth expectation raised to 24-25% from 23-25%.","Wind down of Immersive Healthcare incurred $5M in one-time expenses during Q3 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-24-000116","json":"https://secwatch.observer/filing/0001321732-24-000116.json","markdown":"https://secwatch.observer/filing/0001321732-24-000116.md","text":"https://secwatch.observer/filing/0001321732-24-000116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173224000116/0001321732-24-000116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173224000116/pen-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:06:31.301335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}